Designing neoantigen cancer vaccines, trials, and outcomes

Neoantigen vaccines are based on epitopes of antigenic parts of mutant proteins expressed in cancer cells. These highly immunogenic antigens may trigger the immune system to combat cancer cells. Improvements in sequencing technology and computational tools have resulted in several clinical trials of...

Descripción completa

Detalles Bibliográficos
Autores principales: Biswas, Nupur, Chakrabarti, Shweta, Padul, Vijay, Jones, Lawrence D., Ashili, Shashaanka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947792/
https://www.ncbi.nlm.nih.gov/pubmed/36845151
http://dx.doi.org/10.3389/fimmu.2023.1105420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947792/
https://www.ncbi.nlm.nih.gov/pubmed/36845151
http://dx.doi.org/10.3389/fimmu.2023.1105420

Ejemplares similares